Hull York Medical School, Institute of Clinical and Applied Health Research, University of Hull, Hull, UK
Hull York Medical School, Institute of Clinical and Applied Health Research, University of Hull, Hull, UK.
BMJ Open Respir Res. 2022 Feb;9(1). doi: 10.1136/bmjresp-2021-001155.
Short-acting beta agonist (SABA) overuse (≥3 canisters annually) is associated with worse asthma outcomes and accounts for the majority of greenhouse gas emissions from asthma inhalers in England. Reducing SABA overuse aligns with the National Health Service long-term plan to optimise asthma treatment while minimising environmental impact, but adoption of local asthma guidelines for a SABA-free maintenance and reliever therapy strategy for step 3 asthma patients is limited. In this we describe patient and staff involvement in a codesign process adapted from experience-based codesign (EBCD) principles to develop an implementation-ready intervention within a practice-relevant timescale.The codesigned intervention consists of five pillars: healthcare professional education; implementation of 'gold standard' prescribing practices; targeted asthma reviews; patient education and support; and real-time data monitoring and reporting of asthma care metrics. The codesign process contributed to all pillars and, by identifying potential individual and organisational barriers to implementation, enabled the development of plans to address these barriers.In this we reflect on the strengths and weaknesses of our codesign process, outline how EBCD principles can be used in respiratory research and propose actions for patients, health professionals, researchers and funders to develop the potential of EBCD in respiratory research.
短效β受体激动剂(SABA)的过度使用(每年≥3 罐)与更差的哮喘结局相关,并导致英格兰哮喘吸入器的大部分温室气体排放。减少 SABA 的过度使用符合国民保健制度的长期计划,该计划旨在优化哮喘治疗,同时将环境影响降至最低,但采用当地哮喘指南,为第 3 步哮喘患者提供无 SABA 的维持和缓解治疗策略的做法有限。在本中,我们描述了患者和工作人员参与的一项从基于经验的共同设计(EBCD)原则改编而来的共同设计过程,以便在实践相关的时间范围内开发出一种可实施的干预措施。该共同设计的干预措施包括五个支柱:医疗保健专业人员教育;实施“黄金标准”处方实践;针对性哮喘审查;患者教育和支持;以及实时数据监测和报告哮喘护理指标。共同设计过程为所有支柱做出了贡献,并通过确定实施的潜在个人和组织障碍,制定了应对这些障碍的计划。在本中,我们反思了我们的共同设计过程的优缺点,概述了 EBCD 原则如何用于呼吸研究,并提出了患者、卫生专业人员、研究人员和资助者的行动,以发挥 EBCD 在呼吸研究中的潜力。